LEWIS JOEL bought GALT
November 18, 2025 · Form 4 insider transaction
LEWIS JOEL bought 6,783 shares of Galectin Therapeutics Inc. at $2.39 per share, a transaction worth $16.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,783
Price
$2.39
Total value
$16.2K
InsiderLEWIS JOEL
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 18, 2025
Filing dateNovember 19, 2025
Shares owned after839,375
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.